BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
News on Ranbaxy Laboratories
Weakness in Sun Pharma a buying opportunity: IIFL
12.46 pm | 22 Apr 2015 | Source: CNBC-TV18
The pharma space has been in focus post Sun Pharma-Daiichi deal and the likelihood of a possible merger between Teva and Mylan globally. In an intervi...
Daiichi Sankyo to offload stake in Sun Pharma
8.15 pm | 20 Apr 2015 | Source: PTI
As part of the deal, Ranbaxy shareholders were to receive 0.8 Sun Pharma shares for every Ranbaxy share they held. Daiichi Sankyo, which had acquired ...
Buy Ranbaxy Labs; target of Rs 800: Motilal Oswal
4.52 pm | 30 Jan 2015 | Source: Moneycontrol.com
Brokerage house Motilal Oswal is bullish on Ranbaxy Laboratories and has recommended buy rating on the stock with a target price of Rs 800, in its res...
Accumulate Ranbaxy; target Rs 780: KRChoksey
4.50 pm | 30 Jan 2015 | Source: Moneycontrol.com
KRChoksey is bullish on Ranbaxy Laboratories and has recommended accumulate rating on the stock with a target price of Rs 780 in its January 29, 2015 ...
Quick Links for Ranbaxy Laboratories
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.